Oliver advises on regulatory healthcare law and his clients include major service providers and investors in the healthcare sector - hospitals, operators of medical care centres, laboratory companies, private equity houses, nursing home operators - but also statutory health insurance companies.

 

His practice focuses on the licensing and financing of new facilities as well as large-volume transactions, cooperations, outsourcing and PPP projects. Oliver advises his clients in particular on hospital law, the law governing authorised physicians, the law governing medical professions and the law governing statutory health insurance. He also advises on cooperations and innovative business models in the fields of e-health and telemedicine

 

Oliver is a member of the Management Board of Taylor Wessing Germany.

Show full CV Hide full CV

Latest news & insights

Top Level Change at Taylor Wessing Germany: Olaf Kranz elected as new Managing Partner

30 April 2018

by multiple authors

Click here to find out more
Life sciences & healthcare

Biologics and biosimilars litigation update

7 August 2020
QUICK READ

by Matthew Royle, Ph.D.

Click here to find out more
robotic-arm
Brexit

Brexit readiness for overseas medical devices manufacturers: trade marks

6 August 2020
QUICK READ

by multiple authors

Click here to find out more
DNA helix
Life sciences & healthcare

Paul England writes on COVID-19 drug supply and patent system for Manufacturing Chemist

6 August 2020
QUICK READ

by Paul England, DPhil

Click here to find out more

Related people

Meet me at

There are no upcoming events